Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma
The therapeutic outcome of immune checkpoint inhibition (ICI) can be improved through combination treatments with ICI therapy. Myeloid-derived suppressor cells (MDSCs) strongly suppress tumor immunity. MDSCs are a heterogeneous cell population, originating from the unusual differentiation of neutrop...
Main Authors: | Saima Sabrina, Yuji Takeda, Tomoyuki Kato, Sei Naito, Hiromi Ito, Yuki Takai, Masaki Ushijima, Takafumi Narisawa, Hidenori Kanno, Toshihiko Sakurai, Shinichi Saitoh, Akemi Araki, Norihiko Tsuchiya, Hironobu Asao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/5/1296 |
Similar Items
-
Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma
by: Takafumi Narisawa, et al.
Published: (2023-02-01) -
Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by <i>Bacillus Calmette–Guérin</i>
by: Yuji Takeda, et al.
Published: (2023-11-01) -
Effect of Extracellular Signal-Regulated Protein Kinase 5 Inhibition in Clear Cell Renal Cell Carcinoma
by: Hidenori Kanno, et al.
Published: (2022-07-01) -
Role of the Glycosylphosphatidylinositol-Anchored Protein TEX101 and Its Related Molecules in Spermatogenesis
by: Hiroshi Yoshitake, et al.
Published: (2020-09-01) -
Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
by: Yuta Kurota, et al.
Published: (2023-04-01)